| 000 | 01568 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513154912.0 | ||
| 264 | 0 | _c19990122 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a1120-009X | ||
| 024 | 7 |
_a10.1179/joc.1998.10.5.411 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCutilli, T | |
| 245 | 0 | 0 |
_ap53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation. _h[electronic resource] |
| 260 |
_bJournal of chemotherapy (Florence, Italy) _cOct 1998 |
||
| 300 |
_a411-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aFacial Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aGenes, ras |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aJaw Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xbiosynthesis |
| 700 | 1 | _aPapola, F | |
| 700 | 1 | _aDi Emidio, P | |
| 700 | 1 | _aCorbacelli, A | |
| 773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 10 _gno. 5 _gp. 411-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/joc.1998.10.5.411 _zAvailable from publisher's website |
| 999 |
_c9786547 _d9786547 |
||